Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An osteosarcoma characterized by the presence of atypical cartilage of variable cellularity. It may or may not be associated with the presence of myxoid areas or focal bone formation.
Biomarker and diagnostic research for chondroblastic osteosarcoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
60 publications have been identified in PubMed for chondroblastic osteosarcoma. Research spans Case Report / Case Series (37%), Review / Meta-Analysis (22%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 22 | 37% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:30 AM UTC
Research summaries |
13 |
22% |
Laboratory research | 11 | 18% |
Disease patterns and progression | 8 | 13% |
Testing and diagnosis research | 4 | 7% |
Clinical study results | 2 | 3% |
Hu X (2026). [PMID: 42166004](https://pubmed.ncbi.nlm.nih.gov/42166004/). *Mol Cell Biochem*. [Basic Science / Preclinical]
Jin T (2026). [PMID: 41896410](https://pubmed.ncbi.nlm.nih.gov/41896410/). *J Cell Mol Med*. [Diagnostic / Biomarker]
Hannan A (2026). [PMID: 41509083](https://pubmed.ncbi.nlm.nih.gov/41509083/). *Clinical case reports*. [Case Report / Case Series]
Migliorini F (2026). [PMID: 41340726](https://pubmed.ncbi.nlm.nih.gov/41340726/). *J Orthop*. [Review / Meta-Analysis]
Cui H (2026). [PMID: 42222379](https://pubmed.ncbi.nlm.nih.gov/42222379/). *Front Oncol*. [Case Report / Case Series]
Walsh S (2026). [PMID: 41968090](https://pubmed.ncbi.nlm.nih.gov/41968090/). *J Small Anim Pract*. [Case Report / Case Series]
Du J (2026). [PMID: 41870293](https://pubmed.ncbi.nlm.nih.gov/41870293/). *Clin Invest Med*. [Diagnostic / Biomarker]
Tabatabaei SH (2026). [PMID: 41906181](https://pubmed.ncbi.nlm.nih.gov/41906181/). *J Med Case Rep*. [Case Report / Case Series]
Mohammadi I (2026). [PMID: 41994059](https://pubmed.ncbi.nlm.nih.gov/41994059/). *J Dent (Shiraz)*. [Case Report / Case Series]
Tauro A (2026). [PMID: 42137748](https://pubmed.ncbi.nlm.nih.gov/42137748/). *JFMS Open Rep*. [Case Report / Case Series]